|
PT2417156E
(pt)
|
2009-04-07 |
2015-04-29 |
Roche Glycart Ag |
Anticorpos trivalentes, biespecíficos
|
|
US9676845B2
(en)
|
2009-06-16 |
2017-06-13 |
Hoffmann-La Roche, Inc. |
Bispecific antigen binding proteins
|
|
CN102712696A
(zh)
|
2009-09-16 |
2012-10-03 |
弗·哈夫曼-拉罗切有限公司 |
包含卷曲螺旋和/或系链的蛋白质复合体及其用途
|
|
TW201138821A
(en)
|
2010-03-26 |
2011-11-16 |
Roche Glycart Ag |
Bispecific antibodies
|
|
CN103068846B9
(zh)
|
2010-08-24 |
2016-09-28 |
弗·哈夫曼-拉罗切有限公司 |
包含二硫键稳定性Fv片段的双特异性抗体
|
|
EP2655413B1
(en)
|
2010-12-23 |
2019-01-16 |
F.Hoffmann-La Roche Ag |
Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
|
|
WO2012116926A1
(en)
|
2011-02-28 |
2012-09-07 |
F. Hoffmann-La Roche Ag |
Antigen binding proteins
|
|
JP5768147B2
(ja)
|
2011-02-28 |
2015-08-26 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
一価抗原結合タンパク質
|
|
EP2726494B1
(en)
|
2011-06-28 |
2017-01-04 |
Whitehead Institute For Biomedical Research |
Using sortases to install click chemistry handles for protein ligation
|
|
WO2013065009A1
(en)
*
|
2011-11-01 |
2013-05-10 |
National Institute Of Immunology |
A sortase-click reaction suite for synthesis of multivalent dendrimeric protein assembly
|
|
MX2014009565A
(es)
|
2012-02-10 |
2014-11-10 |
Genentech Inc |
Anticuerpos monocatenarios y otros heteromultimeros.
|
|
US9717685B2
(en)
|
2012-03-26 |
2017-08-01 |
President And Fellows Of Harvard College |
Lipid-coated nucleic acid nanostructures of defined shape
|
|
CA2870485A1
(en)
|
2012-04-13 |
2013-10-17 |
Whitehead Institute For Biomedical Research |
Sortase-modified vhh domains and uses thereof
|
|
US11339208B1
(en)
|
2012-05-31 |
2022-05-24 |
United States Of America As Represented By The Secretary Of The Air Force |
Camelidae single-domain antibodies against Yersinia pestis and methods of use
|
|
US9267127B2
(en)
|
2012-06-21 |
2016-02-23 |
President And Fellows Of Harvard College |
Evolution of bond-forming enzymes
|
|
KR20150030744A
(ko)
|
2012-06-27 |
2015-03-20 |
에프. 호프만-라 로슈 아게 |
표적에 특이적으로 결합하는 하나 이상의 결합 단위를 포함하는 항체 Fc-영역 접합체의 제조 방법 및 그의 용도
|
|
ES2597228T3
(es)
*
|
2012-06-27 |
2017-01-17 |
F. Hoffmann-La Roche Ag |
Procedimiento para la selección y la producción de entidades de objetivación, como dianas, altamente selectivas y multiespecíficas, personalizadas, las cuales contienen por lo menos dos entidades de unión diferentes, y utilización de éstas
|
|
KR20150052085A
(ko)
|
2012-09-14 |
2015-05-13 |
에프. 호프만-라 로슈 아게 |
2개 이상의 상이한 단위를 포함하는 분자의 제조 및 선별 방법, 및 이의 용도
|
|
WO2014145441A1
(en)
|
2013-03-15 |
2014-09-18 |
The Trustees Of The University Of Pennsylvania |
Sortase-mediated protein purification and ligation
|
|
WO2014145654A1
(en)
|
2013-03-15 |
2014-09-18 |
The Trustees Of The University Of Pennsylvania |
Method for the site-specific covalent cross-linking of antibodies to surfaces
|
|
DK3611180T3
(da)
*
|
2013-03-15 |
2022-02-28 |
Biomolecular Holdings Llc |
Hybrid immunoglobulin indeholdende ikke-peptidyl-binding
|
|
AU2014258109B2
(en)
*
|
2013-04-25 |
2016-09-29 |
Abtlas Co., Ltd. |
Method for refining protein including self-cutting cassette and use thereof
|
|
GB2529356B
(en)
*
|
2013-04-28 |
2020-12-23 |
Genequantum Healthcare Co Ltd |
Novel linkers, coupling intermediates, conjugates, preparation method and application thereof
|
|
DK2991683T3
(da)
|
2013-05-02 |
2019-11-04 |
Glykos Finland Oy |
Konjugater af et glykoprotein eller en glykan med en toksisk ladning
|
|
EP3693398A1
(en)
*
|
2013-05-10 |
2020-08-12 |
Whitehead Institute for Biomedical Research |
In vitro production of red blood cells with sortaggable proteins
|
|
US10260038B2
(en)
|
2013-05-10 |
2019-04-16 |
Whitehead Institute For Biomedical Research |
Protein modification of living cells using sortase
|
|
JP2016523978A
(ja)
*
|
2013-07-10 |
2016-08-12 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
核酸−タンパク質複合体に関する組成物及び方法
|
|
WO2015042393A2
(en)
*
|
2013-09-20 |
2015-03-26 |
President And Fellows Of Harvard College |
Evolved sortases and uses thereof
|
|
BR112016006929A2
(pt)
|
2013-10-11 |
2017-09-19 |
Hoffmann La Roche |
Anticorpo, ácido nucleico, vetor de expressão, célula hospedeira, métodos de preparação de anticorpo, de tratamento de pacientes e de geração de um anticorpo, composição farmacêutica e uso do anticorpo
|
|
US10556024B2
(en)
|
2013-11-13 |
2020-02-11 |
Whitehead Institute For Biomedical Research |
18F labeling of proteins using sortases
|
|
CN104844711B
(zh)
*
|
2014-02-18 |
2018-07-06 |
南通表源生物技术有限公司 |
一种多聚体荧光蛋白复合物及其应用
|
|
EP4169944A1
(en)
*
|
2014-03-14 |
2023-04-26 |
Biomolecular Holdings LLC |
Process for preparing hybrid immunoglobulin containing non-peptidyl linkage
|
|
KR102460736B1
(ko)
*
|
2014-05-10 |
2022-10-31 |
소렌토 쎄라퓨틱스, 인코포레이티드 |
화학적으로-로킹된 이중특이적 항체
|
|
CN104130308A
(zh)
*
|
2014-07-29 |
2014-11-05 |
吉林大学 |
一种蛋白质定点peg修饰的方法及所得peg修饰的蛋白质
|
|
US10053683B2
(en)
|
2014-10-03 |
2018-08-21 |
Whitehead Institute For Biomedical Research |
Intercellular labeling of ligand-receptor interactions
|
|
CA2964837C
(en)
|
2014-10-29 |
2023-10-17 |
Ludwig-Maximilians-Universitaet Muenchen |
Means and methods for site-specific functionalization of polypeptides
|
|
WO2016087416A1
(en)
|
2014-12-03 |
2016-06-09 |
F. Hoffmann-La Roche Ag |
Multispecific antibodies
|
|
MX381723B
(es)
|
2014-12-17 |
2025-03-13 |
Hoffmann La Roche |
Metodos novedosos para conjugacion de polipeptido mediada por enzimas usando sortasa.
|
|
JP6800154B2
(ja)
|
2014-12-17 |
2020-12-16 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
結合形成酵素の活性アッセイ
|
|
BR112017010888A2
(pt)
*
|
2014-12-17 |
2018-02-27 |
Hoffmann La Roche |
método para produzir um produto de conjugação enzimática de três polipeptídeos
|
|
KR101637010B1
(ko)
*
|
2015-04-24 |
2016-07-07 |
광주과학기술원 |
위치 특이적으로 알부민이 연결된 요산 산화효소 및 단백질에 위치 특이적으로 알부민을 연결하는 방법
|
|
TWI687228B
(zh)
*
|
2015-05-11 |
2020-03-11 |
美商索倫多醫療公司 |
化學鎖固之雙特異性抗體
|
|
US11123440B2
(en)
|
2015-05-12 |
2021-09-21 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for making antibody conjugates
|
|
WO2016191200A1
(en)
|
2015-05-22 |
2016-12-01 |
Clemson University |
Conotoxin peptides for use in biofouling deterrence
|
|
JP2017043547A
(ja)
*
|
2015-08-24 |
2017-03-02 |
国立研究開発法人理化学研究所 |
ポリペプチドを結合した成長因子及びその利用
|
|
EP3353201B1
(en)
|
2015-09-25 |
2021-09-08 |
F. Hoffmann-La Roche AG |
Recombinant immunoglobulin heavy chains comprising a sortase conjugation loop and conjugates thereof
|
|
EP3353310B1
(en)
|
2015-09-25 |
2020-04-29 |
H. Hoffnabb-La Roche Ag |
Process for producing thioesters employing a sortase a
|
|
CN108138158B
(zh)
|
2015-09-25 |
2021-11-09 |
豪夫迈·罗氏有限公司 |
可溶性分选酶a
|
|
JP6998863B2
(ja)
|
2015-09-25 |
2022-02-04 |
エフ.ホフマン-ラ ロシュ アーゲー |
深共融溶媒におけるソルターゼaを利用したアミド基転移
|
|
US12048753B2
(en)
|
2015-10-01 |
2024-07-30 |
Whitehead Institute For Biomedical Research |
Labeling of antibodies
|
|
EP3377112A4
(en)
|
2015-11-18 |
2019-06-12 |
Sorrento Therapeutics, Inc. |
CHEMICALLY BLOCKED BISPECIFIC ANTIBODIES
|
|
DK3417058T3
(da)
|
2016-02-16 |
2021-11-15 |
Res Found Dev |
Sortase-modificerede molekyler og anvendelser deraf
|
|
ES2911439T3
(es)
|
2016-03-24 |
2022-05-19 |
Genia Tech Inc |
Procedimientos y composiciones de bioconjugación específica de sitio útiles para sistemas de nanoporos
|
|
CN109072212B
(zh)
*
|
2016-03-30 |
2022-10-04 |
豪夫迈·罗氏有限公司 |
改善的分选酶
|
|
CA3021526A1
(en)
|
2016-04-28 |
2017-11-02 |
Forschungsverbund Berlin E.V. |
Unusual substrates of tubulin tyrosine ligase
|
|
AU2017295704B2
(en)
|
2016-07-13 |
2023-07-13 |
President And Fellows Of Harvard College |
Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
|
|
EP4372002A3
(en)
|
2016-09-14 |
2024-08-14 |
The Trustees Of The University Of Pennsylvania |
Proximity-based sortase-mediated protein purification and ligation
|
|
US11298407B2
(en)
*
|
2016-09-21 |
2022-04-12 |
The Governing Council Of The University Of Toronto |
Hemoglobin based oxygen carrier and method of preparation
|
|
US10738338B2
(en)
|
2016-10-18 |
2020-08-11 |
The Research Foundation for the State University |
Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
|
|
RS67792B1
(sr)
|
2016-12-01 |
2026-03-31 |
Regeneron Pharma |
Radio-obeležena anti-pd-l1 antitela za imuno-pet snimanje
|
|
US11951165B2
(en)
|
2016-12-30 |
2024-04-09 |
Vaxcyte, Inc. |
Conjugated vaccine carrier proteins
|
|
IL267709B2
(en)
|
2016-12-30 |
2025-04-01 |
Vaxcyte Inc |
Polypeptide-antigen conjugates with unnatural amino acids
|
|
WO2018141959A1
(en)
|
2017-02-06 |
2018-08-09 |
Innate Pharma |
Immunomodulatory antibody drug conjugates binding to a human mica polypeptide
|
|
WO2018165613A1
(en)
|
2017-03-10 |
2018-09-13 |
Prellis Biologics, Inc. |
Methods and systems for printing biological material
|
|
BR112019018915A2
(pt)
|
2017-03-15 |
2020-04-14 |
Pandion Therapeutics Inc |
imunotolerância direcionada
|
|
US11000604B2
(en)
|
2017-05-17 |
2021-05-11 |
Research Foundation Of The City University Of New York |
Reagent for site-selective bioconjugation of proteins or antibodies
|
|
AU2018273914A1
(en)
|
2017-05-24 |
2019-11-14 |
Pandion Operations, Inc. |
Targeted immunotolerance
|
|
JP2020524483A
(ja)
|
2017-05-25 |
2020-08-20 |
プレリス バイオロジクス,インク. |
三次元印刷された器官、デバイス、およびマトリックス
|
|
DE102017115522B4
(de)
*
|
2017-07-11 |
2019-11-14 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Verfahren zur Herstellung von Block-Polymeren mittels Verknüpfung von Blöcken durch eine Transpeptidase und Block-Polymere erhalten durch Transpeptidase-Verknüpfung
|
|
USRE50550E1
(en)
|
2017-12-06 |
2025-08-26 |
Pandion Operations, Inc. |
IL-2 muteins and uses thereof
|
|
US10946068B2
(en)
|
2017-12-06 |
2021-03-16 |
Pandion Operations, Inc. |
IL-2 muteins and uses thereof
|
|
US10174091B1
(en)
|
2017-12-06 |
2019-01-08 |
Pandion Therapeutics, Inc. |
IL-2 muteins
|
|
JP2021506842A
(ja)
*
|
2017-12-18 |
2021-02-22 |
ヤンセン バイオテツク,インコーポレーテツド |
ポリペプチドの放射性標識
|
|
US11970537B2
(en)
*
|
2017-12-26 |
2024-04-30 |
Nanjing GenScript Biotech Co., Ltd. |
Fusion protein dimer using antibody Fc region as backbone and use thereof
|
|
CN109970856B
(zh)
|
2017-12-27 |
2022-08-23 |
信达生物制药(苏州)有限公司 |
抗lag-3抗体及其用途
|
|
CN111971060B
(zh)
*
|
2017-12-29 |
2023-06-13 |
江南大学 |
募集抗体并靶向肿瘤细胞的双功能分子
|
|
WO2019143631A1
(en)
*
|
2018-01-16 |
2019-07-25 |
Phoenix Biomolecular Engineering Foundation |
Universal viral vaccines
|
|
US11866482B2
(en)
|
2018-02-07 |
2024-01-09 |
Duke University |
System and method for homogenous GPCR phosphorylation and identification of beta-2 adrenergic receptor positive allosteric modulators
|
|
GB201900621D0
(en)
*
|
2019-01-16 |
2019-03-06 |
Ipsen Biopharm Ltd |
Labelled polypeptides
|
|
TWI756621B
(zh)
*
|
2019-01-25 |
2022-03-01 |
大陸商信達生物製藥(蘇州)有限公司 |
新型雙特異性抗體分子以及同時結合pd-l1和lag-3的雙特異性抗體
|
|
AU2020234394B2
(en)
*
|
2019-03-08 |
2024-02-15 |
AbTis Co., Ltd. |
Site-specific antibody conjugation and antibody-drug conjugate as specific example thereof
|
|
CN109750055B
(zh)
*
|
2019-03-13 |
2022-12-23 |
南开大学 |
基于α螺旋把手提高蛋白核酸生物耦合效率的方法
|
|
WO2020210468A1
(en)
|
2019-04-10 |
2020-10-15 |
President And Fellows Of Harvard College |
Nucleic acid nanostructures crosslinked with oligolysine
|
|
AU2020279240A1
(en)
|
2019-05-20 |
2021-12-23 |
Pandion Operations, Inc. |
MAdCAM targeted immunotolerance
|
|
WO2020247724A1
(en)
|
2019-06-07 |
2020-12-10 |
Dana-Farber Cancer Institute, Inc. |
Dna nanostructure-based vaccines
|
|
US20220259617A1
(en)
|
2019-06-13 |
2022-08-18 |
The General Hospital Corporation |
Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells
|
|
WO2021141924A1
(en)
|
2020-01-07 |
2021-07-15 |
Encodia, Inc. |
Methods for stable complex formation and related kits
|
|
US11981715B2
(en)
|
2020-02-21 |
2024-05-14 |
Pandion Operations, Inc. |
Tissue targeted immunotolerance with a CD39 effector
|
|
EP4157883A4
(en)
*
|
2020-06-02 |
2024-12-04 |
Children's Medical Center Corporation |
NANOBODY CONJUGATES (VHH) AND THEIR USES
|
|
CN117083079A
(zh)
*
|
2020-06-02 |
2023-11-17 |
儿童医学中心公司 |
纳米抗体(vhh)缀合物及其用途
|
|
WO2021246557A1
(ko)
*
|
2020-06-05 |
2021-12-09 |
주식회사 프로앱텍 |
특정한 갯수의 알부민이 연결된 요산산화효소-알부민 복합체 및 이의 제조 방법
|
|
BR112023001272A2
(pt)
|
2020-07-24 |
2023-04-04 |
Massachusetts Gen Hospital |
Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células
|
|
CN116685725A
(zh)
|
2020-08-19 |
2023-09-01 |
Encodia 公司 |
顺序编码方法和相关试剂盒
|
|
JP2024512328A
(ja)
*
|
2021-03-05 |
2024-03-19 |
ブリガム・ヤング・ユニバーシティ |
分子内から分子間への立体構造スイッチを使用してタンパク質二量体化を制御する方法
|
|
JP7844499B2
(ja)
|
2021-03-08 |
2026-04-13 |
ジーンクアンタム ヘルスケア (スーチョウ) シーオー., エルティーディー. |
抗体-免疫アゴニストコンジュゲート及びその使用
|
|
EP4448722A4
(en)
*
|
2021-12-14 |
2025-12-03 |
Prellis Biologics Inc |
Three-dimensional synthetic lymphoid organs and organoids for antibody design and testing
|
|
AU2023226512A1
(en)
|
2022-02-23 |
2024-08-29 |
Bright Peak Therapeutics Ag |
Immune antigen specific il-18 immunocytokines and uses thereof
|
|
EP4665378A2
(en)
*
|
2023-02-14 |
2025-12-24 |
Georgia State University Research Foundation, Inc. |
Anti-angiogenic agent and methods of using such agent
|
|
US20250186597A1
(en)
|
2023-08-23 |
2025-06-12 |
Bright Peak Therapeutics Ag |
Targeted immune activation with il-18 immunocytokines
|
|
WO2025041101A1
(en)
|
2023-08-23 |
2025-02-27 |
Bright Peak Therapeutics Ag |
Activatable il-18 immunocytokines and uses thereof
|
|
CN121969385A
(zh)
|
2023-09-11 |
2026-05-01 |
丹娜-法伯癌症研究院 |
含有il-2变体以增强car t细胞的功能性的car-衔接子
|
|
WO2025238253A1
(en)
|
2024-05-16 |
2025-11-20 |
Synaffix B.V. |
Antibody-oligonucleotide conjugates
|
|
WO2026008881A1
(en)
|
2024-07-05 |
2026-01-08 |
Synaffix B.V. |
Extracellular vesicles comprising biomolecule-conjugates
|
|
WO2026069134A1
(en)
|
2024-09-26 |
2026-04-02 |
Bright Peak Therapeutics Ag |
Human therapy with il-18 immunocytokines
|
|
WO2026083296A1
(en)
|
2024-10-16 |
2026-04-23 |
Bright Peak Therapeutics Ag |
Trispecific compositions comprising il-18, vegf binding domains, and pd-1 binding domains
|
|
WO2026083295A1
(en)
|
2024-10-16 |
2026-04-23 |
Bright Peak Therapeutics Ag |
Trispecific compositions comprising il-2, vegf binding domains, and pd-1 binding domains
|
|
WO2026143022A1
(en)
|
2024-12-23 |
2026-07-02 |
Point Loma Nazarene University |
Antibody directed enzyme pro-drug therapy (adept) for cancer treatment using an antibody or fragment that binds to a cd206 receptor and 3-cyclopentyl-alpha-phenylalanine-methotrexate
|